Repos Pharma
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Clinical Safety and Efficacy Study of Mebendazole on GI Cancer or Cancer of Unknown Origin. (NCT03628079) | Repos Pharma | 2018-05-25 |
Track Repos Pharma automatically
Every clearance here is in the API, with alerts when new ones post.